Gene
ARHGAP35
Rho GTPase activating protein 35
Explore in graph →CI-GENE-00011235HGNC:4591 ENSG00000160007 NCBI 2909 CIViC Cancer geneApproved
Curated evidence
Clinical evidence (4)
CIViC items involving this gene, grouped by molecular profile and therapy, with native levels and directions. 50 items per page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 27646271
- Run
- ING-CIVIC-20260908-000001
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| ARHGAP35 A865_L870delinsV1 | ||||||||
| (functional) | —UNRESOLVED | Functional | D | Supports Gain Of Function | 3 | submitted | EID10192A large scale tumor genome analysis identified p190RhoGAP-encoding gene ARHGAP35 to be frequently mutated in endometrial tumours. Mutant and wild-type HA-tagged ARHGAP35 constructs were created and ex… (full text at CIViC) PMID 27646271 · Binamé et al., 2016 · Open in CIViC | civic |
| ARHGAP35 Mutation1 | ||||||||
| (functional) | —UNRESOLVED | Functional | B | Supports Loss Of Function | 3 | submitted | EID12643In TCGA endometrial carcinoma (n = 509), ARHGAP35 was somatically mutated in 108 tumors with 152 mutations at 126 positions (20.2%), and pan cancer analysis showed ARHGAP35 mutations in >2% of all tum… | |
Cohorts
Alteration frequency by cohort (50)
Frequency = cases affected / cases profiled within one cohort. Cohorts are never pooled.
- Source
- cBioPortal for Cancer Genomics (public studies)
- Dataset
- cBioPortal mutated genes by study
- Version
- cbioportal-2026-09-01
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- cohort
- License
- ODC Open Database License (ODC-ODbL) unless otherwise noted per study; attribution to the original studies required
- PMID
- 39031567
- Run
- ING-CBIOPORTAL-20260908-000001
| Cohort | Mapped cancer | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Rank in cohort | Source |
|---|---|---|---|---|---|---|---|
| Endometrial Carcinoma (MSK, Molecular Oncology 2024) ucs_msk_2024 | Endometrial Carcinoma | Ssm | 8 | 25 |
Literature
Linked publications (0)
Data not yet available